血液凝固原理52-5573资料库 ntecede nt,PTA)是㈠种双链蛋白质,介入内 源性凝血途径激活,缺乏时患血友病丙。 (3)激肽释放酶原(prekallikrein,PK)是㈠种单链糖蛋白,介入内源性凝血途径激活,PK 激活后转化为激 肽释放酶(kallikrein,KK
基于26个网页-相关网页
(2)正在微血管内绝对普通的VEC仍对凝血过程产生的Fbn、BK等刺激发生反当,分泌释放t-PA;前释放激肽酶(prekallikrein,PK)取VEC膜上的HMW-K结合(普通VEC膜上有大量HMW-K受体,约106只/粗胞),PK经HMW-...
基于8个网页-相关网页
Prekallikrein activator in albumin BRP 人血清白蛋白
Prekallikrein deficiency 前激肽释放酶缺乏
Prekallikrein activator 前激肽释放酶激活剂 ; 前激肽释放酶原激活剂
Prekallikrein assay 释义前激肽释放酶测定
HPKi - Inactivated Prekallikrein 灭活前激肽释放酶
以上来源于: WordNet
In the paper, a microtiter plate method was used to determine the residual prekallikrein activator(PKA) activity in blood products.
本文应用微量滴定板方法测定血液制品中残留的PKA活性。
The plasma levels of atrial natriuretic factor (ANF) and prekallikrein(PK) were measured in Fatients with essential hypertension and in health subjects as a control.
本文总结了心房利钠因子、前激肽释放酶在高血压病患者血浆中含量的改变。
Plasma levels of prekallikrein (PK), plasminogen (PLG), fibrinogen (FIG) in 84 cases of malignant tumor were studied with an advanced method. Each item was measured 100 times.
应用较为先进的检测手段,对84例恶性肿瘤患者血浆激肽释放酶原(PK)、纤溶酶原(PLG)、纤维蛋白原(FIG)进行测定,共100例次。
应用推荐